If You Invested $10,000 In Johnson & Johnson Stock 10 Years Ago, How Much Would You Have Now?
Johnson & Johnson (NYSE:JNJ) researches, develops, manufactures and sells various products in the health care field worldwide ...
Atopic Dermatitis Affects Millions, And Johnson & Johnson Is Committed To Addressing The Unmet Needs Of Patients
AD, The most common inflammatory skin disorder worldwide, is a highly heterogeneous condition with current treatments that do ...
Johnson & Johnson (NYSE:JNJ) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript January 22, 2025 Johnson & Johnson beats earnings expectations. Reported EPS is $2.04, ...
The Motley Fool9d
Johnson & Johnson Tops Q4 EPS Forecasts
Overall, Johnson & Johnson had a strong quarter, continuing to expand its product pipeline and positioning itself well amid market fluctuations. Johnson & Johnson is a diversified healthcare giant ...
Seeking Alpha17d
What Johnson & Johnson Is Getting With The Acquisition Of Intra-Cellular Therapies
Johnson & Johnson (NYSE ... and the acquisition adds an important commercial product for a growth-starved big pharma company like J&J, and I think that the early-stage pipeline could bring upside ...
Johnson & Johnson-backed medical device company seeks U.S. IPO, Bloomberg says
HistoSonics, a medical device company backed by Johnson & Johnson’s venture capital arm, is exploring the possibility of a U.S. initial ...
“Johnson & Johnson: Buy Rating Reaffirmed Despite Price Target Cut, Growth Prospects Highlighted”
Leerink Partners analyst Marc Goodman maintained a Buy rating on Johnson & Johnson (JNJ – Research Report) yesterday and set a price target ...